EOS imaging is improving the treatment experience for surgeons and patients through their 2D/3D imaging technology and imaged-based solutions for musculoskeletal pathologies and orthopedic surgical care.
"We've been targeting the bone imaging market with equipment that reduces the radiation dose compared to other modern technologies," says Marie Meynadier, PhD, CEO and founder of EOS imaging, headquartered in France. "This is particularly important in pediatrics where our Micro Dose protocol minimizes radiation even further than our standard, low dose exams."
Dr. Meynadier started EOS imaging in the early 2000s, with the company installing its first EOS systems in North America and Europe in 2008. The company leveraged scientific research on radiation detection and other technologies to create solutions that addressed numerous needs in skeletal imaging like the ability to capture the full body in a weight-bearing position at low dose of radiation, and to generate 3D anatomical models.
"Before our equipment, surgeons often only had 2D images of their patients," Dr. Meynadier explains, "Important 3D measurements like torsion and rotation were not available from X-rays. Our 3D models, data sets and planning solutions replace guessing with accurate, realistic simulations."
EOS exams simultaneously capture frontal and lateral 2D images of the patient's entire body or region of interest. Then EOS' propriety software can be used to reconstruct a 3D model of their spine and/or lower limbs. The results allow surgeons to better understand a patient's pathology and make decisions for customized treatment plans.
"EOS images and models are very powerful because thousands of anatomical parameters of the patient are embedded within," Dr. Meynadier says. "This complete patient dataset helps the surgeon decide what needs to be done and how. Being able to plan in 3D avoids surprises and allows all surgeons to enter the OR with confidence."
EOS offers 3D surgical planning solutions for the spine, hip and knee for a more complete understanding of a patient's anatomy and the ability to select the size and position of implants pre-operatively.
"Our technology delivers value to the physician by providing precise measurements and a way to engage the patient in a visual understanding of their condition and treatment options," says Dr. Meynadier.
In November, EOS received FDA 510(k) clearance to market its kneeEOS 3D surgical planning software in the United States. Like the other EOSapps, the online software is based on EOS images and patient-specific data. When the surgeon launches the planning, they begin with an initial proposal of implant size and position. As they adapt the plan, they have real-time feedback on how the changes will affect relevant clinical parameters which can help them ensure everything is optimal prior to the procedure.
"Implant selection can now be based on a particular patient's anatomy, potential risks and lifestyle goals," Dr. Meynadier says. "EOSapps offer surgeons a new way to plan as close to reality as possible."
Since the company’s first installation in 2008, EOS Imaging has grown to close to 200 sites spanning the globe.